Please login to the form below

Not currently logged in


This page shows the latest BioNTech news and features for those working in and with pharma, biotech and healthcare.

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech was the first biotech to bring an mRNA-based individualised cancer vaccine targeting neoantigens into clinical trials. ... BioNTech's chief exec Ugur Sahin. “This financing round is a significant milestone that recognises our scientific and

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied along with checkpoint inhibitors to see if they can deliver a double-whammy to

  • Deal Watch September 2016 Deal Watch September 2016

    At a lower disclosed headline value of $310m BioNTech licensed its mRNA-based cancer vaccines platform to Genentech. ... The full value cannot be determined as BioNTech received the $310m in upfront and near-term milestone payments, no other financial

  • Deal Watch November 2015 Deal Watch November 2015

    Sanofi will gain access to BioNTech's mRNA formulation technology to generate new cancer immunotherapies. ... Option to US co-promote. 1, 700. BioNTech. Sanofi. Collaboration, licence - multi yr.

  • Pharma deals in May 2015 Pharma deals in May 2015

    This omission was rectified this month as Lilly closed a deal with BioNTech. ... 600. BioNTech/ Lilly. Research collaboration. To identify and validate novel tumour targets and corresponding T cell receptors.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....